INTERVIEW: ASEAN Preps For First Dengue Vaccine
This article was originally published in PharmAsia News
As the first vaccine against the dengue virus moves towards initial regulatory filings, experts have met in Asia to consider the potential impact of the product and issues related to its availability.
You may also be interested in...
In line with similar initiatives by Japan on other regulatory fronts, the country's Agency for Medical Research and Development is building up its partnerships and presence in Asia.
Positive clinical results pave path forward for Japanese firm’s potential istradefylline successor.
Curon thinks tenalisib can offer a differentiated and safe new therapy for hematologic cancers such as multiple forms of lymphoma. Axis and PharmaEssentia team up on TCR therapy R&D in Taiwan.